Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Tumor Microbiome Composition Influences Pancreatic Cancer Survival

DOI: 10.1158/2159-8290.CD-RW2019-128 Published October 2019
  • Article
  • Info & Metrics
  • PDF
Loading
  • Major finding: Distinct tumor microbiomes are associated with long- and short-term survival in patients with PDAC.

  • Concept: Tumor microbiota promote recruitment and activation of CD8+ T cells and survival of patients with PDAC.

  • Impact: Modulation of the PDAC microbiome is a potential therapeutic approach for patients with PDAC.


Embedded Image

Gut microbiota can regulate immune responses beyond the gut, and recent studies suggest that gut microbiota may mediate chemotherapeutic and immunotherapeutic responses. Riquelme, Zhang, and colleagues investigated the role of tumor microbial populations in the survival of patients with pancreatic ductal adenocarcinoma (PDAC). Tumor microbial diversity was characterized in two independent cohorts of patients with surgically resected PDAC who were long-term survivors (LTS) or short-term survivors (STS). Compared with STSs, LTSs exhibited increased microbial diversity and enrichment of district bacterial species that correlated with overall survival. Furthermore, higher densities of CD3+ and CD8+ T cells and increased numbers of granzyme B+ cells were found in LTS tumors, and CD8+ T-cell density correlated with the top three enriched bacterial genera in LTSs. Intratumoral microbiome composition also correlated with differential enrichment of metabolic pathways. Comparison of matched gut, tumor, and adjacent normal tissue microbiomes from three patients with PDAC showed that the gut microbiome represents approximately 25% of the tumor microbiome and is absent in adjacent normal tissue. Fecal microbial transplantation (FMT) from STSs to mice previously treated with antibiotics resulted in the presence of bacteria of human origin in both murine gut and tumor. FMT from LTSs, STSs, or healthy controls showed that mice receiving FMT from LTSs exhibited enhanced survival and increased levels of CD8+ T cells and activated CD8+ T cells, whereas mice receiving FMT from STSs exhibited increased levels of CD4+FOXP3+ and myeloid-derived tumor suppressor cells, and T-cell depletion blocked the antitumor effect induced by FMT from LTSs. Collectively, these results suggest that gut microbiota can colonize pancreatic tumors, change intratumoral bacterial composition, recruit and activate CD8+ T cells, and prolong survival of patients with PDAC. Therefore, determining the tumor microbiome of patients with PDAC may serve as a prognostic tool, and FMT from LTS patients may have therapeutic potential.

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 2019;178:795–806.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2019 American Association for Cancer Research.
View Abstract
PreviousNext
Back to top
Cancer Discovery: 9 (10)
October 2019
Volume 9, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Microbiome Composition Influences Pancreatic Cancer Survival
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tumor Microbiome Composition Influences Pancreatic Cancer Survival
Cancer Discov October 1 2019 (9) (10) 1335; DOI: 10.1158/2159-8290.CD-RW2019-128

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor Microbiome Composition Influences Pancreatic Cancer Survival
Cancer Discov October 1 2019 (9) (10) 1335; DOI: 10.1158/2159-8290.CD-RW2019-128
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
  • Deep Learning Algorithm Aids Breast Cancer Detection by Mammography
Show more Research Watch

Microbiome

  • Cross-Reactive Gut Bacteriophage Protein Enhances Anticancer Therapy
  • The Gut Microbiome Dictates Whether Predisposed Mice Develop Leukemia
  • Microbial Inosine Promotes Immune-Checkpoint Blockade Response in Mice
Show more Microbiome
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement